IRIS Institutional Research Information System - OPENBS Open Archive UniBS

MISSALE, Mariacristina
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 15.589
AS - Asia 8.264
EU - Europa 7.295
SA - Sud America 1.494
AF - Africa 193
OC - Oceania 24
Continente sconosciuto - Info sul continente non disponibili 15
Totale 32.874
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 15.352
CN - Cina 3.023
SG - Singapore 2.707
UA - Ucraina 1.800
BR - Brasile 1.261
IT - Italia 976
PL - Polonia 959
DE - Germania 863
HK - Hong Kong 838
FR - Francia 685
FI - Finlandia 577
VN - Vietnam 495
GB - Regno Unito 485
IN - India 370
TR - Turchia 311
IE - Irlanda 296
RU - Federazione Russa 289
BD - Bangladesh 132
CA - Canada 129
AR - Argentina 77
SE - Svezia 74
IQ - Iraq 67
MX - Messico 62
CZ - Repubblica Ceca 55
ZA - Sudafrica 53
BE - Belgio 52
ID - Indonesia 48
EC - Ecuador 45
JP - Giappone 39
IR - Iran 36
NL - Olanda 34
PK - Pakistan 30
ES - Italia 29
KR - Corea 29
NG - Nigeria 27
VE - Venezuela 26
AT - Austria 23
CH - Svizzera 21
KE - Kenya 21
AU - Australia 20
UZ - Uzbekistan 19
CL - Cile 18
CO - Colombia 18
EG - Egitto 18
MA - Marocco 17
PY - Paraguay 16
SA - Arabia Saudita 16
EU - Europa 15
JO - Giordania 14
MU - Mauritius 14
TN - Tunisia 13
UY - Uruguay 12
PE - Perù 11
ET - Etiopia 10
IL - Israele 10
AE - Emirati Arabi Uniti 9
KZ - Kazakistan 9
BG - Bulgaria 8
BO - Bolivia 8
DZ - Algeria 8
AZ - Azerbaigian 7
CR - Costa Rica 7
KG - Kirghizistan 7
RO - Romania 7
BA - Bosnia-Erzegovina 6
GR - Grecia 6
NP - Nepal 6
PA - Panama 6
PS - Palestinian Territory 6
SK - Slovacchia (Repubblica Slovacca) 6
AL - Albania 5
DO - Repubblica Dominicana 5
GT - Guatemala 5
HR - Croazia 5
JM - Giamaica 5
MD - Moldavia 5
OM - Oman 5
AM - Armenia 4
CY - Cipro 4
DK - Danimarca 4
HN - Honduras 4
HU - Ungheria 4
MY - Malesia 4
TT - Trinidad e Tobago 4
EE - Estonia 3
LB - Libano 3
LT - Lituania 3
LU - Lussemburgo 3
LV - Lettonia 3
PT - Portogallo 3
SN - Senegal 3
SV - El Salvador 3
BB - Barbados 2
BH - Bahrain 2
GY - Guiana 2
LA - Repubblica Popolare Democratica del Laos 2
MN - Mongolia 2
NI - Nicaragua 2
NZ - Nuova Zelanda 2
PH - Filippine 2
Totale 32.846
Salva come PNG Salva come JPEG
Città #
Fairfield 1.569
Woodbridge 1.486
Singapore 1.450
Jacksonville 1.290
Ashburn 1.215
Warsaw 953
Houston 920
Hong Kong 835
Ann Arbor 790
Cambridge 681
Seattle 584
Chandler 579
Wilmington 572
San Jose 553
The Dalles 533
Beijing 530
Princeton 527
Nanjing 466
New York 346
Brescia 332
Dublin 295
Helsinki 290
Dearborn 279
Lauterbourg 249
Los Angeles 248
Istanbul 239
Nanchang 182
Ho Chi Minh City 159
Shenyang 148
Munich 141
Des Moines 131
Hebei 131
Milan 118
Moscow 116
Buffalo 115
Tianjin 106
Hanoi 104
Dallas 102
Jinan 98
São Paulo 97
Changsha 92
Shanghai 91
San Francisco 81
San Diego 79
Pune 73
Jiaxing 69
Orem 66
Lancaster 65
Santa Clara 63
London 61
Redondo Beach 61
Toronto 61
Chicago 56
Kunming 51
San Mateo 48
Turku 47
Brussels 46
Hangzhou 46
Council Bluffs 45
Verona 45
Dong Ket 42
Ningbo 41
Rio de Janeiro 39
Brno 38
Brooklyn 36
Denver 36
Kocaeli 36
Augusta 35
Guangzhou 35
Tokyo 35
Frankfurt am Main 33
Phoenix 33
Ardabil 32
Leawood 32
Zhengzhou 32
Rome 31
San Donà Di Piave 31
Montreal 30
Brasília 28
Haikou 28
Johannesburg 28
Monmouth Junction 27
Poplar 27
Taizhou 27
Abuja 26
Boardman 25
Norwalk 24
Manchester 23
Romola 23
Atlanta 22
Mexico City 22
Mumbai 22
Lanzhou 21
Belo Horizonte 20
Chennai 19
Nairobi 19
Haiphong 18
Ankara 17
Baghdad 17
Da Nang 17
Totale 21.932
Salva come PNG Salva come JPEG
Nome #
Redistribution of DAT/α-synuclein complexes visualized by “in situ” proximity ligation assay in transgenic mice modelling early Parkinson’s disease 314
Dopamine transporter/α-synuclein complexes are altered in the post mortem caudate putamen of Parkinson’s disease: An in situ proximity ligation assay study 306
GPNMB/OA protein increases the invasiveness of human metastatic prostate cancer cell lines DU145 and PC3 through MMP-2 and MMP-9 activity 297
Pre-synaptic dopamine D(3) receptor mediates cocaine-induced structural plasticity in mesencephalic dopaminergic neurons via ERK and Akt pathways 271
The Contribution of -Synuclein Spreading to Parkinson’s Disease Synaptopathy 263
Nicotine-induced structural plasticity in mesencephalic dopaminergic neurons is mediated by dopamine d3 receptors and akt-mtorc1 signaling 261
Antisecretive and Antitumor Activity of Abiraterone Acetate in Human Adrenocortical Cancer: A Preclinical Study. 248
Bright light exposure reduces TH-positive dopamine neurons: implications of light pollution in Parkinson's disease epidemiology. 235
The "in situ" proximity ligation assay to probe protein-protein interactions in intact tissues 227
IN VITRO ANTITUMOR ACTIVITY OF PROGESTERONE IN HUMAN ADRENOCORTICAL CARCINOMA 226
Alpha-synuclein modulates NR2B-containing NMDA receptors and decreases their levels after rotenone exposure 224
Alpha-synuclein/synapsin III pathological interplay boosts the motor response to methylphenidate 219
Role of Dopamine D2/D3 Receptors in Development, Plasticity, and Neuroprotection in Human iPSC-Derived Midbrain Dopaminergic Neurons 208
Synapsin III is a key component of α-synuclein fibrils in Lewy bodies of PD brains 208
Alpha-synuclein aggregation and cell death triggered by energy deprivation and dopamine overload are counteracted by D2/D3 receptor activation 192
A mechanism additional to cyclic AMP accumulation for vasoactive intestinal peptide-induced prolactin release. 191
The D3 dopamine receptor: From structural interactions to function. 190
Palbociclib inhibits proliferation of human adrenocortical tumor cells 189
The proximity ligation assay: an high throughput technique for protein analysis in neuroscience 183
A new pharmacological approach to the facilitation of acetylcholine transmission. 179
Age-related changes of enkephalin in rat spinal cord 178
α-synuclein and synapsin III cooperatively regulate synaptic function in dopamine neurons 177
Shp-2 knockdown prevents l-dopa-induced dyskinesia in a rat model of Parkinson's disease 177
[Functional relation of dopamine receptor stimulation and ionic fluxes in lactotroph cells]. 176
Persistent activation of the D1R/Shp-2/Erk1/2 pathway in L-DOPA-induced dyskinesia in the 6-hydroxy-dopamine rat model of Parkinson's disease 176
Depletion of Progranulin Reduces GluN2B-Containing NMDA Receptor Density, Tau Phosphorylation, and Dendritic Arborization in Mouse Primary Cortical Neurons 174
From α-synuclein to synaptic dysfunctions: new insights into the pathophysiology of Parkinson's disease 172
Acute hemodynamic effects of the two dopaminergic agonists ibopamine and dihydroergotamine, a comparison with the parent compound. 170
A superfusion method for the study of calcium fluxes from pituitary cells. 168
Receptor Heteromers in Parkinson's Disease and L-DOPA-Induced Dyskinesia 168
Synapsin III alterations in Parkinson's disease 166
Acute scopolamine treatment decreases dopamine metabolism in rat hippocampus and frontal cortex 165
Derivation of midbrain dopaminergic neurons from human inducible pluripotent stem cells to model neurological disorders. 164
Mitochondrial Dysfunction and Alpha-Synuclein Synaptic Pathology in Parkinson’s Disease: Who’s on First? 163
Dopamine D3 and acetylcholine nicotinic receptor heteromerization in midbrain dopamine neurons: Relevance for neuroplasticity 163
The 5-alpha reductase inhibitor finasteride reduces dyskinesia in a rat model of Parkinson's disease 163
Nerve growth factor suppresses the transforming phenotype of human prolactinomas 161
Bifunctional compounds targeting both D2 and non-α7 nACh receptors: design, synthesis and pharmacological characterization. 161
Cellular mechanisms for neurotensin receptor-mediated release of prolactin. 161
The novel hybrid agonist HyNDA-1 targets the D3R-nAChR heteromeric complex in dopaminergic neurons 161
Identification of neurotensin receptors associated with calcium channels and prolactin release in rat pituitary. 159
ALPHA-SYNUCLEIN MODULATES SYNAPSIN III IN NIGROSTRIATAL DOPAMINERGIC NEURONS: IMPLICATIONS FOR PARKINSON'S DISEASE 159
Opposing roles for D-1 and D-2 dopamine receptors in the regulation of lower esophageal sphincter motility in the rat. 154
Lack of coupling of D2 receptors to adenylate cyclase in GH3 cells exposed to epidermal growth factor. Possible role of a differential expression of Gi protein subtypes 154
Nerve growth factor in the anterior pituitary: localization in mammotroph cells and co-secretion with prolactin by a dopamine-regulated mechanism 154
Involvement of Synapsin III in the onset of alpha-synuclein synaptic pathology in Parkinson’s disease 153
Nicotine prevents alpha-synuclein accumulation in mouse and human iPSC-derived dopaminergic neurons through activation of the dopamine D3- acetylcholine nicotinic receptor heteromer 153
Caveolins in rhabdomyosarcoma 151
Nerve growth factor and retinoic acid interactions in the control of small cell lung cancer proliferation. 150
Nerve growth factor directs differentiation of the bipotential cell line GH-3 into the mammotroph phenotype 148
Ormoni Anteroipofisari 147
Synapsin III is a key component of α-synuclein fibrils in Lewy bodies of Parkinson’s disease and dementia with Lewy bodies, 147
Nerve growth factor promotes the differentiation of pituitary mammotroph cells in vitro 146
Epidermal growth factor induces the functional expression of dopamine receptors in the GH3 cell line 145
Dopaminergic inhibition of prolactin release and calcium influx induced by neurotensin in anterior pituitary is independent of cyclic AMP system. 144
Modification of the function of D1 and D2 dopamine receptors in striatum and nucleus accumbens of rats chronically treated with haloperidol. 144
PGRN gene silencing in primary neuronal cultures: a model of FTLD-U 144
Dimerization of dopamine D1 and D3 receptors in the regulation of striatal function 143
Synapsin III Alteration in Parkinson's disease 143
A direct interaction between dopamine D1 receptor and phosphatase Shp-2 triggers Erk activation in striatal neurons 141
Involvement of Synapsin III in the onset of Alpha-synuclein pathology in Parkinson’s Disease 141
Neuropeptidergic inhibitory regulation of met-enkephalin immunoreactive material release from rat spinal cord in vitro. 140
Stimulation of dopamine D-2 receptors increases potassium permeability in mammotrophs. 140
AAV-mediated overexpression of alpha-synuclein in midbrain dopamine neurons of Synapsin III knockout mice reveals novel molecular features involved in Parkinson's disease pathology. 140
Differential effects of caffeine on dihydroxyphenylacetic acid concentrations in various rat brain dopaminergic structures 139
Pharmacological basis for dopamine D-2 receptor diversity 139
D2 dopamine receptors associated with inhibition of dopamine release from rat neostriatum are independent of cyclic AMP. 139
Chronic lead exposure alters dopaminergic mechanisms in rat pituitary 138
Repeated administration of (−) sulpiride and SCH 23390 differentially up-regulate D-1 and D-2 dopamine receptor function in rat mesostriatal areas but not in cortical-limbic brain regions 138
Nuclear Factor-κB Dysregulation and α-Synuclein Pathology: Critical Interplay in the Pathogenesis of Parkinson’s Disease 138
Acute hemodynamic and neurohumoral effects of the oral dopamine derivative ibopamine in patients with heart failure. 137
The NMDA/D1 receptor complex as a new target in drug development 137
Chronic lead exposure differentially affects dopamine transport in rat striatum and nucleus accumbens. 137
Synapsin III Alteration in Parkinson's disease 137
Generation of two human induced pluripotent stem cell lines, UNIBSi012-A and UNIBSi013-A, from two patients with treatment-resistant depression 137
Different neurotransmitter systems are involved in the development of esophageal achalasia 136
Nerve growth factor and bromocriptine: a sequential therapy for human bromocriptine-resistant prolactinomas 134
Role of receptor heterodimers in the development of L-dopa-induced dyskinesias in the 6-hydroxydopamine rat model of Parkinson's disease. 134
CaMKII-dependent phosphorylation regulates SAP97/NR2A interaction 133
Dopamine receptors are present in rat and human esophagus 133
Dopamine D3 receptors are critically involved in the neurotrophic effects of cocaine and nicotine on the mouse mesencephalic dopaminergic neurons 133
Critical role of dopamine D3 receptor in structural plasticity generated by exposure to drugs of addiction in mesencephalic dopaminergic neurons 133
Nerve growth factor signaling in prostate health and disease. 133
Afferent fibers mediate the increse of met-enkephalin elicited in rat spinal cord by localized pain. 132
[Dopaminergic receptors in the cardiovascular system: their biochemical characterization and pharmacological importance]. 132
Nerve growth factor, D2 receptor isoforms, and pituitary tumors 132
Angiotensin II differentially affects cyclic AMP formation in intact adrenal glomerulosa cells and in purified membrane preparations 131
Sex-related variations in serum nerve growth factor concentration in humans. 131
Identification of D2 dopaminergic receptors in bovine adrenal cortex. 131
Evidence for the presence of D1 and D2 dopamine receptors in the rat adrenal cortex 131
Peripheral and central mechanisms of action of serotoninergic anorectic drugs. 131
The differential coupling mechanism of dopamine D-2 receptor subtypes: importance for the actions of neuroleptic drugs 131
Evidence for the presence of both D-1 and D-2 dopamine receptors in human esophagus. 130
Dopamine receptors and brain function 130
Reciprocal regulation of dopamine D1 and D3 receptor function and trafficking by heterodimerization 130
Effect of suloctidil on dopaminergic transmission in various rat brain areas: possible uses as a drug for the elderly 130
Dopamine D3 receptor heteromerization: Implications for neuroplasticity and neuroprotection 130
The tyrosine phosphatase Shp-2 interacts with the dopamine D(1) receptor and triggers D(1) -mediated Erk signaling in striatal neurons. 129
Differential up-regulation of D-1 and D-2 dopamine receptor function in mesostriatal areas but not in cortical-limbic brain regions of rats chronically treated with (?)sulpiride and SCH 23390 129
Nerve growth factor suppresses the tumoral phenotype of human prolactinomas 128
Totale 16.338
Salva come PNG Salva come JPEG
Categoria #
all - tutte 157.512
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 157.512
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021120 0 0 0 0 0 0 0 0 0 0 0 120
2021/20222.156 195 455 54 72 16 49 138 121 88 277 177 514
2022/20231.786 306 18 38 139 151 527 5 161 274 39 61 67
2023/20241.763 110 32 142 132 93 372 60 53 387 30 44 308
2024/20254.242 23 46 58 545 471 346 407 105 511 286 877 567
2025/20268.205 753 1.112 658 1.335 755 558 1.229 322 495 686 218 84
Totale 33.696